Anti-Clozapine - (Clone CLO-1256) - 1.0 mg

Primary Monoclonal Antibodies

2 - 8°C Wet Ice

Clozapine, a unique atypical antipsychotic, is primarily employed in the treatment ofschizophrenia, particularly in cases resistant to other antipsychotic medications.Introduced in the 1970s, clozapine stands out due to its distinct mechanism of action, primarily antagonizing dopamine receptors, but also influencing other neurotransmittersystems, including serotonin, histamine, and adrenergic receptors. This broad-spectrummodulation contributes to its efficacy in managing symptoms. Notably, clozapine isassociated with a risk of agranulocytosis, a potentially life-threatening reduction in whiteblood cell count. Due to this risk, regular blood monitoring, specifically complete bloodcell counts, is crucial for individuals on clozapine therapy. These diagnostic tests areessential for detecting early signs of agranulocytosis, allowing for prompt interventionand ensuring the overall safety and effectiveness of clozapine treatment in patients withsevere or treatment-resistant schizophrenia.

≥1.0 mg/ml